Safeguard Scientifics, Inc. (NYSE:SFE) Major Shareholder Purchases $51,718.34 in Stock

Safeguard Scientifics, Inc. (NYSE:SFEGet Rating) major shareholder Thomas A. Satterfield, Jr. purchased 13,646 shares of Safeguard Scientifics stock in a transaction that occurred on Wednesday, May 25th. The shares were bought at an average cost of $3.79 per share, for a total transaction of $51,718.34. Following the completion of the transaction, the insider now directly owns 476,904 shares in the company, valued at approximately $1,807,466.16. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Safeguard Scientifics stock traded up $0.06 during midday trading on Friday, hitting $4.28. 27,568 shares of the company were exchanged, compared to its average volume of 37,785. The company’s fifty day moving average price is $4.47 and its 200-day moving average price is $5.92. Safeguard Scientifics, Inc. has a fifty-two week low of $3.32 and a fifty-two week high of $8.98. The company has a market cap of $71.16 million, a PE ratio of -86.40 and a beta of 1.05.

Safeguard Scientifics (NYSE:SFEGet Rating) last announced its earnings results on Thursday, May 5th. The asset manager reported ($0.40) earnings per share (EPS) for the quarter.

Several institutional investors and hedge funds have recently made changes to their positions in the business. Yakira Capital Management Inc. raised its position in shares of Safeguard Scientifics by 8.1% in the 1st quarter. Yakira Capital Management Inc. now owns 1,092,108 shares of the asset manager’s stock valued at $5,701,000 after purchasing an additional 82,158 shares in the last quarter. First Manhattan Co. raised its position in shares of Safeguard Scientifics by 1.5% in the 1st quarter. First Manhattan Co. now owns 992,316 shares of the asset manager’s stock valued at $5,179,000 after purchasing an additional 14,260 shares in the last quarter. Madison Avenue Partners LP raised its position in shares of Safeguard Scientifics by 48.7% in the 3rd quarter. Madison Avenue Partners LP now owns 965,242 shares of the asset manager’s stock valued at $8,571,000 after purchasing an additional 316,209 shares in the last quarter. Contrarian Capital Management L.L.C. raised its position in shares of Safeguard Scientifics by 6.5% in the 4th quarter. Contrarian Capital Management L.L.C. now owns 746,542 shares of the asset manager’s stock valued at $5,487,000 after purchasing an additional 45,644 shares in the last quarter. Finally, CM Management LLC raised its position in shares of Safeguard Scientifics by 4.3% in the 4th quarter. CM Management LLC now owns 600,000 shares of the asset manager’s stock valued at $4,410,000 after purchasing an additional 25,000 shares in the last quarter. 60.59% of the stock is currently owned by institutional investors.

Separately, StockNews.com began coverage on Safeguard Scientifics in a research report on Saturday, May 21st. They set a “hold” rating on the stock.

About Safeguard Scientifics (Get Rating)

Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.

See Also

Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.